Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 3
Submit an article Journal homepage
693
Views
13
CrossRef citations to date
0
Altmetric
Original Articles: Research

Anti-tumor efficacy study of the Bruton’s tyrosine kinase (BTK) inhibitor, ONO/GS-4059, in combination with the glycoengineered type II anti-CD20 monoclonal antibody obinutuzumab (GA101) demonstrates superior in vivo efficacy compared to ONO/GS-4059 in combination with rituximab

Tomoko YasuhiroOno Pharmaceutical Co, Ltd, Osaka, Japan;
,
Wako SawadaOno Pharmaceutical Co, Ltd, Osaka, Japan;
,
Christian KleinRoche Pharmaceutical Research & Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland
,
Ryohei KozakiOno Pharmaceutical Co, Ltd, Osaka, Japan;
,
Shingo HottaOno Pharmaceutical Co, Ltd, Osaka, Japan;
&
Toshio YoshizawaOno Pharmaceutical Co, Ltd, Osaka, Japan; Correspondence[email protected]
Pages 699-707 | Received 12 Feb 2016, Accepted 08 Jun 2016, Published online: 09 Aug 2016
Supplemental material

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Download Zip (7.1 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.